نتایج جستجو برای: personalized treatment advanced

تعداد نتایج: 1620631  

حسینی برشنه, علی, خادمی, محمد, سلطانی, دانش, مدرسی, محمد حسین, ویسی, نگار,

Breast cancer that is caused by the accumulation of genetic and epigenetic alterations, is one of the main causes of death resulted from cancer. Various therapeutic approaches have been introduced for this cancer and the traditional diagnosis and treatment is based on the prognosis estimation using cancer anatomic features (TNM system) and clinical results, but studies show different responses ...

2017
Chun-mei Kuang Xiang Fu Yi-jun Hua Wen-di Shuai Zhi-hua Ye Yingchang Li Qi-hua Peng Yi-zhuo Li Shuai Chen Chao-nan Qian Wenlin Huang Ran-yi Liu

Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients who do not respond to cisplatin suffer, rather than benefit, from chemotherapy treatment. The goal of this study was to identify molecules involved in cisplatin resistance and to clarify their molecular mechanisms, which wou...

2016
Jeong Gu Kang Jeong‐Heon Ko Yong‐Sam Kim

Personalized medicine has emerged as a widely accepted trend in medicine for the efficacious and safe treatment of various diseases. It covers every medical treatment tailored according to various properties of individuals. Cancer-associated glycosylation mirrors cancer states more precisely, and this "sweet side of cancer" is thus intended to spur the development of an advanced in vitro diagno...

Journal: :JOP : Journal of the pancreas 2009
Laura R Triano Bryan W Chang Muhammad Wasif Saif

The results of the trials presented at this year's ASCO annual meeting underline the challenges of not only treating but also studying locally advanced pancreatic cancer, with any appreciable effect of treatment gained at the cost of considerable toxicity. That response was observed in small numbers of patients in the presented trials speaks to the importance of rational selection of treatment ...

2013
Dragana Klinac Elin S. Gray Michael Millward Mel Ziman

Despite extensive scientific progress in the melanoma field, treatment of advanced stage melanoma with chemotherapeutics and biotherapeutics has rarely provided response rates higher than 20%. In the past decade, targeted inhibitors have been developed for metastatic melanoma, leading to the advent of more personalized therapies of genetically characterized tumors. Here we review current melano...

Journal: :acta medica iranica 0
hilda samimi endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran. parviz fallah department of laboratory sciences, faculty of allied medicine, alborz university of medical sciences, karaj, iran. alireza naderi sohi department of nanotechnology and tissue engineering, stem cell technology research center, tehran, iran. rezvan tavakoli department of molecular biology and genetic engineering, stem cell technology research center, tehran, iran. mahmood naderi liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, iran. masoud soleimani department of hematology, faculty of medical sciences, tarbiat modares university, tehran, iran.

personalized medicine is a set of diagnostic, prognostic and therapeutic approaches in which medical interventions are carried out based on individual patient characteristics. as life expectancy increases in developed and developing countries, the incidence of diseases such as cancer goes up among people in the community. cancer is a disease that the response to treatment varies from one person...

Journal: :Asian Journal of Pharmaceutical and Clinical Research 2022

Personalized medication (PM) is a wide and progressed field of medical science with more accuracy to educate every individual’s clinical data. This model categorizes individuals within discrete subject groups accountability, utility, or products being customized each group based on their expected response. It an emergent rapidly developing method practice which utilizes advanced technologies th...

Journal: :acta medica iranica 0
babak arjmand endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran. parisa goodarzi brain and spinal cord injury research center, neurosciences institute, tehran university of medical sciences, tehran, iran. fereshteh mohamadi-jahani brain and spinal cord injury research center, neurosciences institute, tehran university of medical sciences, tehran, iran. khadijeh falahzadeh endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran. bagher larijani diabetes research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran.

personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. this approach has established based on pharmacogenetic and pharmacogenomic information and data. the terms precision and personalized medicines are sometimes applied interchangeably. however, there has been a shift from “personalized medicine” towards “precision me...

2013
Hong Zheng Jia-Yu Liu Feng-Ju Song Ke-Xin Chen

Ovarian cancer is one of the most lethal malignant gynecological tumors. More than 70% of patients with ovarian cancer are diagnosed at advanced stage. The 5-year survival in patients with advanced ovarian cancer is less than 30% because of the lack of effective biomarkers for diagnosis, prognosis, and personalized treatment. MicroRNA (miR) is a class of small noncoding RNAs that negatively reg...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید